NRT Smoking Cessation Aids in Greece

Publication Date	May 2009
Publisher	Euromonitor
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	EUR00392

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's NRT Smoking Cessation Aids in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

NRT gum, NRT patches, NRT inhalators, other

Data coverage:

market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the smoking cessation aids industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Nrt Smoking Cessation Aids in Greece
Euromonitor International
May 2009
List of Contents and Tables
- Executive Summary
- OTC Healthcare Sees Steady Retail Value Growth Despite Economic Downturn
- Demand for Natural Products Increases
- Trend of Health and Wellness Benefits Dynamic Players
- Healthfood Stores Find Prosperous Ground for Expansion
- Saturation in Key Categories Expected To Lead To Slowdown in Growth
- Key Trends and Developments
- Increased Migration and Returning Greeks Influence Demand for Products
- the Debate on Reimbursement of "lifestyle Medications"
- Stressful Lifestyles of Consumers Benefit OTC Healthcare
- Alternative Therapies and Their Impact
- Manufacturers Acknowledge the Significance of Communication
- Market Indicators
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Market Data
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Penetration of Private Label by Sector 2003-2008
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
- OTC Registration and Classification
- Advertising
- Packaging
- Labelling
- Distribution
- Vitamins & Dietary Supplements Registration and Classification
- EU Legislation
- Self-medication and Preventative Medicine
- Generics
- Switches
- Definitions
Summary 1 Research Sources
- Alapis SA
- Strategic Direction
- Key Facts
Summary 2 Alapis SA: Key Facts
Summary 3 Alapis SA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Elpen SA
- Strategic Direction
- Key Facts
Summary 4 Elpen SA: Key Facts
Summary 5 Elpen SA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 6 Elpen SA: Competitive Position 2008
- Korres Natural Products SA
- Strategic Direction
- Key Facts
Summary 7 Korres Natural Products SA: Key Facts
Summary 8 Korres Natural Products SA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 9 Korres Natural Products SA: Competitive Position 2008
- Lavipharm Sa, Laboratoires
- Strategic Direction
- Key Facts
Summary 10 Laboratoires Lavipharm SA: Key Facts
Summary 11 Laboratoires Lavipharm SA: Operational Indicators
- Company Background
- Production
Summary 12 Laboratoires Lavipharm SA: Production capacity 2008
- Competitive Positioning
Summary 13 Laboratoires Lavipharm SA: Competitive Position 2008
- Sarantis Sa, Gr
- Strategic Direction
- Key Facts
Summary 14 Sarantis SA, Gr: Key Facts
Summary 15 Sarantis SA, Gr: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 16 Sarantis SA, Gr: Competitive Position 2008
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Sector Indicators
- Table 12 Number of Smokers by Gender 2003-2008
- Sector Data
- Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
- Table 15 NRT Gum Flavours: % Value Breakdown 2006-2008
- Table 16 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 17 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
- Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013